H51.20
Internuclear ophthalmoplegia, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Internuclear ophthalmoplegia (INO) is a neurological condition that affects eye movements, causing difficulty in coordinating movements between the eyes. The unspecified eye designation indicates that the condition may involve either eye without specific localization. This condition is often linked to damage in a part of the brainstem called the medial longitudinal fasciculus, which plays a critical role in synchronized eye movements.
Causes & Symptoms
Clinical Causes: Multiple sclerosis, especially common in young adults and those with autoimmune conditions Stroke or transient ischemic attack affecting the brainstem Brain tumors or lesions in the brainstem region Trauma or head injury resulting in damage to the neural pathways Infections that impact the central nervous system
Key Symptoms: Difficulty coordinating eye movements between the eyes Nystagmus, or involuntary eye oscillations, particularly in the affected eye Double vision, especially when looking in specific directions Weakness or paralysis in the muscles controlling eye movement Problems with gaze fixation or smoothly following objects
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a detailed neurological examination, including assessments of eye movements. Imaging studies such as MRI or CT scans are often utilized to identify lesions or damage within the brainstem. Additional tests may include eye movement recordings and assessment of visual fields to evaluate the extent of impairment.
Treatment Protocols: Treatment depends on the underlying cause of the internuclear ophthalmoplegia. Managing conditions such as multiple sclerosis or stroke is crucial. Supportive therapies may include eye patching or prisms to alleviate double vision, and neurological or occupational therapy may assist in adapting to visual deficits. In cases linked to inflammation or infections, appropriate medications are prescribed. Recovery varies depending on the severity of the brain damage and the response to treatment, with some patients experiencing significant improvement over time.
Clinical Advice & FAQs
Billing Guidance
Is H51.20 a billable ICD-10 code?
Yes, H51.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H51.20?
Clinical documentation must specify the nature of Internuclear ophthalmoplegia, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference